Beth G. Oliva represents manufacturers, distributors, retailers, and trade associations in regulatory, litigation and legislative matters and has spent nearly twenty years representing the tobacco and nicotine industry. She handles a wide range of regulatory issues before the Food and Drug Administration, as well as other U.S. federal and state agencies. While she represents clients at all levels of the distribution chain, she specifically represents manufacturers from research and design through product commercialization as well as through their life cycle on the US market. Beth also has extensive experience with state and federal government affairs and routinely drafts legislation, testifies in front of state legislatures and negotiates. In addition, Beth has significant experience working with scientific issues. She has worked with scientific and medical personnel in the U.S., Canada, Europe and the Middle East to advise product manufacturers on regulatory and duty-of-care issues. Further, Beth has worked with scientific consultants, expert witnesses, and scientific literature both to support regulatory submissions and to prepare defenses in domestic and international product liability litigation. Beth serves on the Board of Directors for the Food and Drug Law Institute (FDLI), the Board of Directors of the Nicotine Resource Consortium (NRC), and the Organization of Women in Nicotine and Tobacco (OWNiT) and is the Chair of the Global Forum for Nicotine and Tobacco (GTNF).
Beth G. Oliva represents manufacturers, distributors, retailers, and trade associations in regulatory, litigation and legislative matters and has spent nearly twenty years representing the tobacco and nicotine industry. She handles a wide range of regulatory issues before the Food and Drug Administration, as well as other U.S. federal and state agencies. While she represents clients at all levels of the distribution chain, she specifically represents manufacturers from research and design through product commercialization as well as through their life cycle on the US market. Beth also has extensive experience with state and federal government affairs and routinely drafts legislation, testifies in front of state legislatures and negotiates. In addition, Beth has significant experience working with scientific issues. She has worked with scientific and medical personnel in the U.S., Canada, Europe and the Middle East to advise product manufacturers on regulatory and duty-of-care issues. Further, Beth has worked with scientific consultants, expert witnesses, and scientific literature both to support regulatory submissions and to prepare defenses in domestic and international product liability litigation. Beth serves on the Board of Directors for the Food and Drug Law Institute (FDLI), the Board of Directors of the Nicotine Resource Consortium (NRC), and the Organization of Women in Nicotine and Tobacco (OWNiT) and is the Chair of the Global Forum for Nicotine and Tobacco (GTNF).